Protective and anti-angiopathy effects of caffeic acid phenethyl ester against induced type 1 diabetes in vivo

International Immunopharmacology

Volumn 17, Issue 2, 2013, Pages 408-414

  Abduljawad, Soha H ^a   El Refaei, Mohamed F ^b   El Nashar, Nermeen N ^b  

^a TAIBAH UNIVERSITY   (Saudi Arabia)

^b MENOUFIA UNIVERSITY   (Egypt)

Author keywords

Angiostatic and CAPE; Anti angiopathy; Anti diabetic; Anti inflammatory

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANTIDIABETIC AGENT; CAFFEIC ACID PHENETHYL ESTER; CYCLOSPORIN A; ENDOSTATIN; GAMMA INTERFERON; GELATINASE B; GLUCOSE; HEMOGLOBIN; INSULIN; INTERLEUKIN 1BETA; NITRIC OXIDE; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ANTIDIABETIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DIABETES CONTROL; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; IMMUNOREGULATION; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; LEUKOCYTE COUNT; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET CELL; PRIORITY JOURNAL; THROMBOCYTE COUNT; VALIDITY;

ANGIOSTATIC AND CAPE; ANTI-ANGIOPATHY; ANTI-DIABETIC; ANTI-INFLAMMATORY;

ANIMALS; BLOOD GLUCOSE; CAFFEIC ACIDS; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; ENDOSTATINS; HUMANS; INSULIN; INTERFERON-GAMMA; INTERLEUKIN-1BETA; ISLETS OF LANGERHANS; MALE; MATRIX METALLOPROTEINASE 9; MICE; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE; PHENYLETHYL ALCOHOL; VESICULAR TRANSPORT PROTEINS;

EID: 84881502702     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2013.06.019     Document Type: Article

References (40)

1. Gispen WH, Biessels GJ. Cognition and mellitus and blood glucose concentrations remained. Neuroscience 2000;23:542-9.
2. Foulis AK. The pathogenesis of cell destruction in Type 1 (insulin-dependent) diabetes mellitus. J Pathol 1987;152:141-8. (Pubitemid 17102763)
3. Rother KI. Diabetes treatment-bridging the divide. N Engl J Med 2007;15: 1499-501.
4. Major CD, GaoZ Y, Wolf BA. Activation of the sphingomyelinase/ceramide signal transduction pathway in insulin secreting beta-cells: role in cytokine induced beta-cell death. Diabetes 1999;48:1372-80. (Pubitemid 29297298)
5. Lehmann PV, Sercerz EE, Forsthuber T, Dayan CM, Gammon G. Determinant spreading and the dynamics of the autoimmune T cell repertoire. Immunol Today 1993;14:203-7.
6. Faust A, Rothe H, Schade U, Lampeter E, Kolb H. Primary nonfunction of islet grafts in autoimmune diabetic nonobese diabetic mice is prevented by treatment with interleukin-4 and interleukin-10. Transplantation 1996;62:648-52. (Pubitemid 26313910)
7. Suarez-Pinzon W, Sorensen O, Bleackley RC, Elliott JF, Rajotte RV, Rabinovitch A. β-Cell destruction in NOD mice correlates with Fas (CD95) expression on β-cells and proinflammatory cytokines expression in islets. Diabetes 1999;48:21-8. (Pubitemid 29019348)
8. Hayden MR, Tyagi SC. Vasa vasorum in plaque angiogenesis, metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: a malignant transformation. Cardiovasc Diabetol 2004;4:1-19.
9. Dulak J, Deshane J, Jozkowicz A, Agarwal A. Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis. Circulation 2008;15: 231-41.
10. Tahergorabi Z, Khazaei M. Imbalance of angiogenesis in diabetic complications: the mechanisms. Int J Prev Med 2012;12:827-38.
11. Xu L, Kanasaki K, Kitada M, Koya D. Diabetic angiopathy and angiogenic defects. Fibrogenesis Tissue Repair 2012;5:1-9.
12. Stahl A, Joyal JS, Chen J, Sapieha P, Juan AM, Hatton CJ, et al. SOCS3 is an endogenous inhibitor of pathologic angiogenesis. Blood 2012;4:925-2929.
13. Aso K, Kanno S, Tadano T, Satoh S, Ishikawa M. Inhibitory effect of propolis on the growth of human leukemia U937. Biol Pharm Bull 2004;27:727-30. (Pubitemid 41694681)
14. Scheller S, Krol W, Swiacik J, Owczarek S, Gabrys J, Shani J. Antitumoral property of ethanolic extract of propolis in mice-bearing Ehrlich carcinoma, as compared to bleomycin. Z Naturforsch C 1989;44:1063-5.
15. Orsolic N, Sver L, Terzí S, Basi CI, Peroral C. application of water-soluble derivative of propolis (WSDP) and its related polyphenolic compounds and their influence on immunological and antitumour activity. Vet Res Commun 2005;29:575-793.
16. Sforcin JM, Bankova V. Propolis: is there a potential for the development of new drugs. J Ethnopharmacol 2011;133:253-60.
17. Song YS, Park EH, Jung KJ, Jin C. Inhibition of angiogenesis by propolis. Arch Pharm Res 2002;25:500-4. (Pubitemid 43057296)
18. Dasyukevich O, Solyanik G. Comparative study of anticancer efficacy of aonitinecontaining agent bc1 against ascite and solid forms of Ehrlich's carcinoma. Exp Oncol 2007;29:317-9. (Pubitemid 351236324)
19. Broad AJ, Sk Sutherland, Coluter AR. The lethality in mice of dangerous Australian and other snake venom. Toxicon 1979;17:661-3.
20. Wright JR, Fraser RB, Kapoor S, Cook HW. Essential fatty acid deficiency prevents multiple low-dose streptozotocin induced diabetes in naive and cyclosporinetreated low-responder murine strains. Acta Diabetol 1995;32:125-30.
21. Trinder P. Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J Clin Pathol 1969;22:158-61.
22. Singleton JR, Smith AG, Bromberg MB. Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care 2001;24: 1448-53. (Pubitemid 33716436)
23. Kendrey G, Roe FJC. Histopathological changes in the pancreas of the laboratory rats. Lab Anim 1969;3:207-20.
24. Miranda KM, Espey MG, Wink DA. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 2001;5:62-71. (Pubitemid 34146173)
25. Kraft JR. IMx (Abbott) immunoassay of insulin: a practical alternative to RIA hyperinsulinemia identification in idiopathic neurootology and other hyperinsulin metabolic disorders. Int Tinnitus J 1997;3:113-6.
26. El-Refaei MF, El-Naa MM. Inhibitory effect of caffeic acid phenethyl ester on mice bearing tumor involving angiostatic and apoptotic activities. Chem Biol Interact 2010;186:152-6.
27. Aref S, Salama O, Shamaa S, El-Refaei M, Mourkos H. Angiogenesis factor pattern differs in acute lymphoblastic leukemia and chronic lymphocytic leukemia. Hematology 2007;12:319-24. (Pubitemid 47180659)
28. Awara WM, el-Sisi AE, el-Refaei M, el-Naa MM, el-Desoky K. Insulinotropic and antiinflammatory effects of rosiglitazone in experimental autoimmune diabetes. Rev Diabet Stud 2005;2:146-56.
29. Serreze DV, Gaskins HR, Leiter EH. Defects in the differentiation and function of antigen presenting cells in NOD/Lt Mice. J Immunol 1993;150:2534-43. (Pubitemid 23127500)
30. Orsolic N, Terzic S, Mihaljevic Z, Sver L, Basic I. Effects of local administration of propolis and its polyphenolic compounds on tumor formation and growth. Biol Pharm Bull J 2005;28:1928-33. (Pubitemid 41437083)
31. Carrasco-Legleu CE, Márquez-Rosado L, Fattel-Fazenda S, Arce-Popoca E, Pérez-Carreón JI, Villa-Treviño S. Chemoprotective effect of caffeic acid phenethyl ester on promotion in a medium-term rat hepatocarcinogenesis assay. Int J Cancer 2004;10:488-92. (Pubitemid 38036647)
32. Mahmoud NN, Carothers AM, Grunberger D, Bilinski RT, Churchill MR, Martucci C, et al. Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis. Carcinogenesis 2000;21:921-7. (Pubitemid 30265135)
33. Jung UJ, Lee MK, Park YB, Jeon SM, Choi MS. Antihyperglycemic and antioxidant properties of caffeic acid in db/db mice. 2006;318:476-83.
34. Durmus M, Yilmaz HR, Efkan UZ, Özcelik N. The effect of caffeic acid phenethyl ester (CAPE) treatment on levels ofMDA, NO and antioxidant enzyme activities in retinas of streptozotocin-induced diabetic rats. Turk J Med Sci 2005;38:525-30.
35. + T cells. J Diabet Complications 1997;11:176-9.
36. Natarajan K, Singh Jr S, Burke TR, Grunberger D, Aggarwal BB. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. Proc Natl Acad Sci 1996;20:9090-5. (Pubitemid 26282023)
37. Kowluru RA. Role of matrix metalloproteinase-9 in the development of diabetic retinopathy and its regulation by H-Ras. Invest Ophthalmol Vis Sci 2010;51: 4320-6.
38. Rishi P, Bhende PS. Images in clinical medicine. Proliferative diabetic retinopathy. N Engl J Med 2009;26:912.
39. Smith JM, Steel DH. Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy. Cochrane Database Syst Rev 2011;5:CD008214.
40. Calderari S, Chougnet C, Clemessy M, Kempf H, Corvol P, Larger E. Angiopoietin 2 alters pancreatic vascularization in diabetic conditions. PLoS One 2012;7:e29438.